Vote Scores
Filings read through

Black Diamond Therapeutics, Inc.: how funds voted at the meeting of 26 Jun 2026

Ticker
BDTX
Meeting
Season
year to 30 June 2026
Filers reporting
117
Ballot items
4

117 filers on Form N-PX reported votes at the Black Diamond Therapeutics, Inc. meeting of 26 Jun 2026. The records fall into 4 ballot items. The page lists them in ballot order: items of the company first, then proposals from security holders. Each bar shows how the reporting filers split. It is not the result of the meeting.

If the reporting person has not received confirmation of the actual number of votes cast prior to filing a report on Form N-PX, the numbers reported may reflect the number of shares instructed to be cast. A reporting person is not required to amend a previously filed Form N-PX report if the reporting person subsequently receives confirmation of the actual number of votes cast.

The words of the SEC. Source: Form N-PX and its instructions, Special Instructions D.5 and D.8, copied on .

The words of this site: the filer writes each filing. The SEC does not say that it checked the votes. A lender does not vote shares that are on loan. A later filing (Form N-PX/A) can replace an earlier filing, and the site uses the latest.

The figures on this page count the filers that report on Form N-PX and the shares they reported. They do not count all votes cast at the meeting.

The page gives records. It gives no investment advice and no advice on how to vote.

Season on this page: year to 30 June 2026. Filings read through . How the figures are made

The ballot

ForAgainstAbstain, withhold or otherAmber tick: the part cast against management

  1. Item 1: Director elections

    2 nominees. 29.2% of the reported votes are for. 32 filers withheld from or voted against at least one nominee.

    140 vote records from 37 filers. 19 of the 37 filers that marked the item voted against management.

    • Positions of 19 fund families
    • For 5
    • Abstain or withhold 10
    • Split or no vote 4
    • Against management 10
  2. Item 2: Advisory vote on executive pay (say-on-pay)

    176 vote records from 116 filers. 7 of the 110 filers that marked the item voted against management. 6 filers gave no management mark.

    • Positions of 24 fund families
    • For 22
    • Against 2
    • Against management 2
  3. Item 3: Frequency of the say-on-pay vote

    One year: 104 filers. Three years: 6 filers. Not applicable: 2 filers. For: 1 filer.

    177 vote records from 116 filers. 6 of the 111 filers that marked the item voted against management. 5 filers gave no management mark.

    • Positions of 24 fund families
    • Split or no vote 24
    • Against management 2
  4. Item 4: Audit-related items (auditor ratification)

    70 vote records from 37 filers. 0 of the 37 filers that marked the item voted against management.

    • Positions of 19 fund families
    • For 19

Positions of the fund families

A position is not the vote of each fund. The position of a family is the way most of the shares reported by its filers were voted. Funds of one family can vote in different ways.

KeyForAgainstAbstain or withholdSplit or no voteAgainst management

Fund families at Black Diamond Therapeutics, Inc., meeting of 26 Jun 2026Families in name order. "Abstain" includes withhold. "Split" includes no vote. "No report" means that no filer of the family listed the item.
Fund family2. Say-on-pay3. Pay-vote frequency4. Auditor
American CenturyForSplitFor
BlackRock and iSharesForSplitFor
BNY MellonAgainst, against managementSplitNo report
Charles SchwabForSplitFor
DimensionalForSplit, against managementFor
EquitableForSplitFor
Federated HermesForSplitNo report
FidelityForSplitFor
Franklin TempletonForSplitFor
Goldman SachsForSplitFor
InvescoForSplitFor
Jackson National fundsForSplit, against managementFor
John Hancock and ManulifeForSplitFor
Morgan Stanley, Eaton Vance and CalvertForSplitNo report
NationwideAgainst, against managementSplitFor
Neuberger BermanForSplitNo report
Northern Trust and FlexSharesForSplitFor
PGIM and PrudentialForSplitFor
ProShares and ProFundsForSplitFor
State Street and SPDRForSplitNo report
T. Rowe PriceForSplitFor
VanguardForSplitFor
Victory CapitalForSplitFor
WisdomTreeForSplitFor

Questions

How many filers reported votes at the Black Diamond Therapeutics, Inc. meeting?
117 Form N-PX filers reported votes at the meeting of 26 Jun 2026. On say-on-pay, 7 of 110 filers that marked the item voted against management (6.4%).
Is this the result of the meeting?
No. The page counts the filers that report on Form N-PX, and the shares they reported. Black Diamond Therapeutics, Inc. reports the result of a vote on Form 8-K.
Why does the page show counts only for director elections?
A director record names the nominee. This site has no page and no row about a person. For director elections it keeps the number of nominees and the split of votes.

Provenance: SEC EDGAR, Form N-PX and N-PX/A filings that list Black Diamond Therapeutics, Inc. with a meeting date within three days of 26 Jun 2026. A proposal title is the most common wording among filers. Where a wording can name a person, the SEC category is shown. The filers wrote the filings. Filings read through .